Congenital Hearing Loss

ehlers danlos syndrome chromosome :: Article Creator Response To Clinical And Genetic Aspects Of Ehlers-Danlos Syndrome, Classic Type I read with interest the review of the clinical and genetic aspects of Ehlers-Danlos syndrome (EDS) by Malfait et al.1 This otherwise excellent review was weakened by the cursory discussion of pain associated with EDS. The authors do not include assessment and characterization of pain in the recommendations for initial evaluation, and pain is only briefly mentioned in management of musculoskeletal manifestations (Anti-inflammatory drugs may help with joint pain), prevention of musculoskeletal manifestations (Individuals with muscle hypotonia and joint instability with chronic pain may have to adjust lifestyle and professional choices accordingly), and under emotional support (Emotional support and behavioral and psychological therapy may be indicated to accept and cope…with the long-term chronic pain). Chronic pain

chromosome 12 syndrome :: Article Creator Understanding The Difference Between Down Syndrome And Autism Down syndrome and autism spectrum disorder can both involve a need for additional support. However, these are distinct diagnoses with different underlying causes and presentations. Down syndrome (DS) and autism spectrum disorder (ASD) are both developmental disorders, conditions present from childhood that affect typical growth and development. While DS and ASD may both require additional support and can share symptoms related to developmental delay, important differences set them apart. Although they both fall under the broad category of developmental disorders, DS and ASD are separate conditions. DS is a genetic disorder, while ASD is a neurodevelopmental disorder. Their specific classifications indicate their primary difference — underlying cause. Underlying causes DS is caused by the presence of a

thalassemia low iron :: Article Creator Exhausted? Irritable? It Could Be Undiagnosed Iron Deficiency About three years ago, Soumya Rangarajan struggled day after day with exhaustion, headaches, and heart palpitations. As a front-line hospital doctor during the COVID-19 pandemic, she first attributed her symptoms to the demands of an unprecedented health care crisis. But a social media post got Rangarajan thinking about the possibility that she might actually be the victim of something more mundane: an iron deficiency. She requested a blood test from her doctor, and the results determined she had anemia, a condition caused by lower-than-normal levels of iron in the blood. It was the first step toward relief, recalled Rangarajan, who is a geriatrician at the University of Michigan. Her symptoms, she added, had made it so she "had difficulty getting through a full week at work." Although estimates vary, some research suggests that abou

blood disorders that cause excessive bleeding :: Article Creator When Your Girl Has Unusual Menstrual Bleeding Menstrual irregularities are a common experience for adolescent girls, especially in the first few years after their first period. While some variability in menstrual cycles is normal, unusually heavy or persistently irregular bleeds can sometimes be a sign of underlying health issues. Abnormal menstrual bleeding refers to any irregularity in the menstrual cycle. This can include periods that are unusually heavy or light, last longer than usual, or occur between regular periods. While some degree of irregularity can be normal and common in adolescent girls as the body adapts to new hormone changes, persistent or severe cases might indicate a health problem. Heavy menses and blood loss can also lead to anaemia, where the body lacks enough red blood cells, causing tiredness and fatigue. Causes Here are some causes of menstrual i

congenital hearing loss in one ear :: Article Creator Hearing Loss News Aug. 15, 2024 — A new study found in adult power loom weavers, chronic noise exposure not only increased their blood pressure overall, but also each year of exposure increased their odds of having high blood ... May 10, 2024 — As often as four days a week, Boeing EA-18G Growler electronic attack aircraft based at Naval Air Station Whidbey Island fly loops overhead as pilots practice touch-and-go landings. The noise is ... Mar. 6, 2024 — Certain factors associated with developing age-related hearing loss differ by sex, including weight, smoking behavior, and hormone exposure, according to a new ... Mar. 4, 2024 — A new cell phone app developed by physician-scientists, which uses artificial intelligence (AI) to accurately diagnose ear infections, or acute otitis media (AOM), could help decrease unnecessary ... Feb. 26, 2024 — While it's not surprising to spot

von willebrand :: Article Creator Basking Biosciences Doses First Patients In Phase 2 Clinical Trial Of Reversible Thrombolytic BB-031 For Acute Ischemic Stroke Novel RNA aptamer designed to inhibit the function of von Willebrand Factor and promote thrombolysis COLUMBUS, Ohio, September 10, 2024--(BUSINESS WIRE)--Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing a novel acute thrombolytic therapy, today announced that the first patients have been dosed in RAISE, a Phase 2 clinical trial evaluating BB-031 in patients presenting with acute ischemic stroke (AIS). "We are excited to announce the initiation of patient enrollment in the RAISE trial," said Richard Shea, Chief Executive Officer of Basking. "This milestone brings us closer to delivering a next-generation therapy that we believe will offer patients a new targeted thrombolytic option beyond traditional fibrinolytics." RAISE is a